<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ddr21709-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float">
 <label>TABLE 1</label>
 <caption>
  <p>Therapeutics targeting viral entry</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <thead valign="bottom">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="bottom" rowspan="1" colspan="1">Target</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Specific effect/target molecule</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Intervention(s)</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Status of SARS‐CoV‐2 trial</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Sponsor/collaborators</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">NCT number</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td rowspan="2" align="left" valign="top" colspan="1">TMPRSS2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Sialic receptors</td>
    <td align="left" valign="top" rowspan="1" colspan="1">DAS181</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Not applicable</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Renmin Hospital of Wuhan University, Ansun Biopharma, Inc.</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04324489</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Serine protease inhibitor</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Camostat Mesilate</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1, phase 2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">University of Aarhus</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04321096</td>
   </tr>
   <tr>
    <td rowspan="7" align="left" valign="top" colspan="1">Endosome</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Endosomal acidification</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Chloroquine diphosphate</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">FundaÃ§Ã£o de Medicina Tropical Dr. Heitor Vieira Dourado, Marcus VinÃcius GuimarÃ£es de Lacerda, Mayla Gabriela Silva Borba, Wuelton Marcelo Monteiro, Gisely Cardoso de Melo, Fernando Fonseca de Almeida e Val, Felipe Gomes Naveca, Maria Paula Gomes MourÃ£o, Ludmila AbrahÃ£o Hajjar, Jorge Souza MendonÃ§a</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04323527</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Endosomal acidification</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Chloroquine or Hydroxychloroquine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Not applicable</td>
    <td align="left" valign="top" rowspan="1" colspan="1">University of Oxford</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04303507</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Endosomal acidification</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Colchicine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 2, Phase 3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lucio Manenti, Azienda Ospedaliero‐Universitaria di Parma, Montreal Heart Institute, DACIMA Software</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04322565, NCT04322682</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Lysosome</td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <p>†1 Bromhexine hydrochloride tablets</p>
     <p>†2 Arbidol hydrochloride</p>
     <p>†3 Recombinant human interferon Î ± 2b spray</p>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Not applicable</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Second Affiliated Hospital of Wenzhou Medical University, WanBangDe Pharmaceutical Group Co., Ltd.</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04273763</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Lysosome</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hydroxychloroquine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Early Phase 1, Phase 2, Phase 3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">National Institute of Respiratory Diseases, Mexico, Sanofi; Columbia University; National Institute of Respiratory Diseases, Mexico, Sanofi; University of Minnesota; Rambam Health Care Campus, Rabin Medical Center; Shanghai Public Health Clinical Center</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04315896, NCT04318444, NCT04318015, NCT04308668, NCT04323631, NCT04261517</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Lysosome</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hydroxychloroquine sulfate</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">University Hospital, Akershus</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04316377</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Lysosome</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Thalidomide</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou Central Hospital</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04273581</td>
   </tr>
   <tr>
    <td rowspan="9" align="left" valign="top" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <p>†1 N‐acetylcysteine + Fuzheng Huayu tablet</p>
     <p>†2 N‐acetylcysteine + placebo</p>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ShuGuang Hospital, Hubei Hospital of Traditional Chinese Medicine, Jingmen No.1 Peopleâ€™s Hospital, Tongji Hospital</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04279197</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Nitric oxide</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Massachusetts General Hospital, Xijing Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04305457, NCT04306393, NCT04312243</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Nitric oxide 0.5%/nitrogen 99.5% gas for Inhalation</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">University of British Columbia, Mallinckrodt</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT03331445</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <p>†1 Abidol hydrochloride</p>
     <p>†2 Abidol hydrochloride combined with interferon atomization</p>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tongji Hospital</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04254874</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Anti‐ SARS‐CoV‐2 plasma</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 2, Phase 3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Mayo Clinic; Foundation IRCCS San Matteo Hospital, OSPEDALE CARLO POMA ASST MANTOVA, OSPEDALE MAGGIORE LODI, OSPEDALE ASST CREMONA; Wuhan Union Hospital, China; Peking Union Medical College Hospital, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04323800, NCT04325672, NCT04321421, NCT04264858, NCT04261426</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Arbidol</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Jieming QU, Ruijin Hospital</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04260594</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">CD147</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Meplazumab</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1, Phase 2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tang‐Du Hospital</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04275245</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Baricitinib</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hospital of Prato</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04320277</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Spike glycoprotein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Human amniotic fluid</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Early Phase 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">University of Utah</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04319731</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="ddr21709-ntgp-0001">
  <fn id="ddr21709-note-0001">
   <p>
    <italic>Note:</italic> †1, †2, and †3 are different arms of parallel intervention.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
